(BUSINESS WIRE)--March 23, 2006: CRF Inc., the world leader in electronic Patient Reported Outcomes (e- PRO) and wireless data collection solutions for the biopharmaceutical industry, today announced that its TrialMax (TM) eDiary technology is now available in Arabic, Hebrew, and Thai. This new language support increases CRF's ability to accommodate more patients, clinical sites and clinical trial sponsors.
"Many of the global clinical trials conducted today would not have been possible even five or six years ago," said Pamela McNamara, Chief Executive Officer of CRF. "With the
adoption of new technologies like eDiaries clinical trials have become increasingly complex, mandating the need for patients in several countries using many languages. Our
TrialMax technology now offers our pharmaceutical clients the ability to connect with even more clinical sites and patients around the globe."
This addition of Arabic, Hebrew, and Thai increases CRF's TrialMax(TM) eDiary technology capability to 57 languages. TrialMax(TM) allows clinical trial sponsors to quickly and
efficiently design very complex patient reported outcome tools to support global clinical studies and collect more reliable patient reported data.
8:56:11 AM 
|
|
